First Ever Patch for Treating Parkinson's Disease Symptoms

Wednesday, May 09, 2007

Ijeoma Eleazu, PharmD

Okay, the photo might be a blast from the past for some but you'll get the connection by the time you get to the end of this post!

Today the FDA approved the first ever skin patch for treating the symptoms of early Parkinson's disease. Neupro (Rotigotine) belongs to a class of drugs known as dopamine agonists. The patch, manufactured by Schwarz Pharma, delivers a continuous dose of the medication through the skin over a 24-hour period and will need to be replaced every day.

Common side effects of the patch include reactions of the skin at the application site, nausea, vomiting, dizziness, drowsiness, and insomnia. All these side effects are not uncommon for this particular class of drugs. Outside of these more common side effects some potential safety concerns include the possibility of hallucinations, sleep attacks (suddenly falling asleep while performing routine activites such as driving or operating machinery), and a drop in blood pressure upon standing up.

Neupro will be available in doses of 2, 4, 6, and 8mg per 24-hour patches in a silicone base.

Photo courtesy of carla216

Labels: dopamine, michael j. fox, parkinsons, patch

Permalink | Email Post

The Healthline Site, its content, such as text, graphics, images, search results, HealthMaps, Trust Marks, and other material contained on the Healthline Site ("Content"), its services, and any information or material posted on the Healthline Site by third parties are provided for informational purposes only. None of the foregoing is a substitute for professional medical advice, examination, diagnosis, or treatment. Always seek the advice of a physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on the Healthline Site. If you think you may have a medical emergency, call your doctor or 911 immediately. Please read the Terms of Service for more information regarding use of the Healthline Site.